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E-cigarettes induce toxicological 
effects that can raise the cancer risk
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Buschini  2, Mirca Lazzaretti2, Laura Marchi2, Vladimiro Cardenia  3, Maria Teresa Rodriguez-
Estrada 3,4, Maura Lodovici5, Caterina Cipriani5, Antonello Lorenzini6, Eleonora Croco6, Silvia 
Marchionni  6, Paola Franchi7, Marco Lucarini7, Vincenzo Longo8, Clara Maria Della Croce8, 
Andrea Vornoli8, Annamaria Colacci9, Monica Vaccari9, Andrea Sapone1 & Moreno Paolini1
Electronic cigarettes (e-cigs) are devices designed to deliver nicotine in a vaping solution rather than 
smoke and without tobacco combustion. Perceived as a safer alternative to conventional cigarettes, 
e-cigs are aggressively marketed as lifestyle-choice consumables, thanks to few restrictions and a lack 
of regulatory guidelines. E-cigs have also gained popularity among never-smokers and teenagers, 
becoming an emergent public health issue. Despite the burgeoning worldwide consumption of 
e-cigs, their safety remains largely unproven and it is unknown whether these devices cause in vivo 
toxicological effects that could contribute to cancer. Here we demonstrate the co-mutagenic and 
cancer-initiating effects of e-cig vapour in a rat lung model. We found that e-cigs have a powerful 
booster effect on phase-I carcinogen-bioactivating enzymes, including activators of polycyclic aromatic 
hydrocarbons (PAHs), and increase oxygen free radical production and DNA oxidation to 8-hydroxy-
2′-deoxyguanosine. Furthermore, we found that e-cigs damage DNA not only at chromosomal level in 
peripheral blood, such as strand breaks in leucocytes and micronuclei formation in reticulocytes, but 
also at gene level such as point mutations in urine. Our results demonstrate that exposure to e-cigs 
could endanger human health, particularly among younger more vulnerable consumers.
The lack of tobacco combustion, the most attractive feature of e-cigarettes (e-cigs), still allows smokers to inhale 
the aerosol in the same way as conventional cigarettes. E-cigs provide a copying mechanism for conditioned 
smoking by replacing some of the rituals associated with the automatic gestures of “regular” smoking1. Moreover, 
the possibility to use e-cigs in smoke-free places, the lack of specific regulations and the perceived potential for 
harm reduction1 make e-cigs very popular. For all these reasons, e-cigs are considered an alternative to tobacco 
cigarettes and an effective strategy to quit smoking. Contrary to the general belief that the lack of tobacco com-
bustion typical of electronic nicotine-delivery systems avoids the production of harmful chemicals, the high tem-
perature reached by e-cig solutions (>200 degrees Celsius)2 can generate dozens of toxic substances3–5, including 
tobacco-specific PAHs, nitrosamines, metals, carbonyl compounds such as acrolein and formaldehyde, which is 
classified as carcinogenic to humans (group 1, by the International Agency for Research on Cancer, IARC) and 
acetaldehyde, possibly carcinogenic (group 2B)3. Although e-cigs contain lower levels of these substances than 
tobacco cigarettes, these toxic mixtures have given rise to recent safety concerns3–5, stressing the need for appro-
priate toxicological data on these devices. The aim of the present study was to investigate several toxicological 
aspects associated with e-cig use including their mutagenic and co-mutagenic potential in a rat model.
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Results and Discussion
The volatile compounds (VOCs) disclosed by the GC/MS analysis on the e-cig aerosol were in agreement with 
the literature3, 5, 6. The main VOCs detected in our study were propylene glycol (PG), nicotine and vegetable glyc-
erin (VG), together with other minor compounds and flavours (such as 1,2-propanediamine, methyl propionate, 
indole, propanoic acid 1-methylpropyl ester, acetol, 1-methoxy-2-propyl acetate, 3-hexen-1-ol, diacetyl and acr-
olein) (Table 1). In particular, heating of VG produces temperature-dependent amounts of hazardous aldehydes 
(such as formaldehyde, acetaldehyde and acrolein), due to thermal decomposition by free-radical dehydration 
of glycerol: formaldehyde, acetaldehyde and acrolein are formed at 600 °C, whereas acrolein is produced in some 
ionic environments at 350 °C7.
Since variables such as device brand, device wattage, resistive heating wire, nicotine concentration, PG/VG 
ratio and puff duration could significantly influence the emission of hazardous compounds (e.g. acrolein) and 
the rate at which nicotine is emitted per unit time8, we recorded the changes in the VOC profile throughout the 
exposure to e-cig vapour. No significant differences (P > 0.05) were found in the VOC composition of the dif-
ferent exposure chambers during animal treatment. This finding and the constant PG/VG ratio confirm that the 
same e-cig aerosol composition was supplied to the animals and no devices overheated. On the other hand, no 
trace of formaldehyde was detected, probably due to the procedure used to determine the VOC profile that entails 
derivatization steps, leading to selective determination of VOCs. However, no significant changes (P > 0.05) were 
detected in the amounts of acrolein (0.02–0.03% of total VOCs), VG or PG, suggesting that similar amounts of 
other aldehydes (not detected) were supplied throughout the treatment cycles, so the effects detected on the rats 
are related to all the compounds formed by e-liquid vaporization and present in the aerosol.
To explore whether e-cigs induce toxicological effects, such as those involving cytochrome P450 (CYP) 
changes9, we analysed the modulation of carcinogen-metabolizing enzymes in the lungs of rats exposed to e-cig 
vapour (see Methods). We observed a significant increase in CYP1A1/2 (activating, for example, polychlorin-
ated biphenyls, aromatic amines, dioxins and PAHs), CYP2B1/2 (activating olefins and halogenated hydrocar-
bons), 2C11 (activating nitrosamines and mycotoxins) and CYP3A (activating hexamethyl phosphoramide and 
nitrosamines) documented by the sharp rise in the corresponding probes (Fig. 1a). Extrapolated to humans, the 
corresponding boosted CYP-linked monooxygenases would predispose a subject to an enhanced cancer risk from 
the widely bioactivated e-cig vapour procarcinogens associated with an increased risk of lung cancer with CYP 
induction and/or CYP polymorphisms10. The overproduction of reactive oxygen species (ROS) resulting from 
CYP induction is one of the well-documented ways in which CYP can play a key role in new cancer occurrence 
via a co-carcinogenesis mechanism11. Until the early 1990s, this phenomenon was initially associated only with 
induction of the CYP2E1 isoform. Then in 1996, we found that virtually all upregulated CYP isoforms can over-
produce ROS12 primarily by uncoupling the CYP catalytic cycle.
We then used the electron paramagnetic resonance “EPR-radical probe” technique to evaluate the free rad-
ical content in lung. We found a significant increase in radical species yield in the lung (Fig. 1b,c). Our data 
are consistent with those recently reported by Sussan et al.13 showing e-cig vapour induced the development of 
oxidative stress in the lung. It is reasonable to hypothesize that the CYP induction found here, together with the 
free radicals present in the aerosol13, 14, contributed to the higher levels of ROS detected in exposed rats. Notably, 
we observed that the antioxidant enzymes catalase, DT-diaphorase and superoxide dismutase were all markedly 
reduced (Fig. 1d). Conversely, the conjugating phase II glutathione S-transferases, mainly involved in xenobiotic 
detoxification, were noticeable decreased, whereas UDP-glucuronyl-transferase was substantially unchanged 
(Fig. 1e). Thus, the reduced activity of antioxidant machinery, the free radicals reported to be present in vapour 
Chamber 1 Chamber 5
Statistical 
significanceMean
Standard 
deviation Mean
Standard 
deviation
1,2-Propanediamine 0.83 0.08 1.09 0.11 ns
Acrolein 0.02 0.00 0.03 0.02 ns
Indole 0.19 0.24 0.18 0.02 ns
Acetol* 0.07 0.03 0.07 0.00 ns
3-Hexen-1-ol* 0.05 0.00 0.06 0.02 ns
Diacetyl* 0.03 0.01 0.08 0.01 ns
Propylene glycol (PG) 87.71 1.03 88.66 0.19 ns
1-Methoxy-2-propyl acetate 0.07 0.04 0.05 0.01 ns
Methyl propionate* 0.20 0.01 0.21 0.06 ns
Propanoic acid, 1-methylpropyl 
ester 0.09 0.00 0.09 0.02 ns
Nicotine 6.36 0.62 6.54 0.18 ns
Glycerin (VG) 4.36 1.68 2.98 0.05 ns
PG/VG 21.80 8.63 29.80 0.43 ns
Table 1. Volatile compounds (VOCs) detected in the first and last treatment chambers during exposure to 
e-cig vapour. Values are expressed as percentage (%) of total peak area of VOCs; factorial analysis of variance 
(ANOVA) was performed to study the effect of exposure cycling on the formation of VOCs. Statistically 
different means were investigated (Tukey’s test, P < 0.05); *flavor compounds.
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along with those generated by CYP induction found here can contribute to the inflammatory response6, 13, 15 and 
suggest an impairment of redox homeostasis in the lung.
To examine whether these phenomena affect the antioxidant power, we measured the systemic antioxidant 
capacity using the ferric reducing antioxidant power (FRAP) approach, finding a markedly reduced FRAP value 
in the lung (Fig. 2a). A similar trend was observed in plasma, even if statistical significance was not reached 
(P = 0.059) (Fig. 2b). Interestingly, plasma FRAP levels and measurement of carbonyl residues (CO) as biomark-
ers of oxidative injury to proteins were inversely correlated in e-cig vapour-exposed rats (Fig. 2c). In contrast, 
animals from the control group showed the opposite behaviour (Fig. 2d), indicating that control animals were 
able to increase their antioxidant capacity in relation to oxidative stress, while the lack of a protective antioxidant 
response in e-cig-exposed animals might explain the reduced FRAP level associated with CO formation. We also 
measured guanosine oxidation to 8-hydroxy-2′-deoxyguanosine (8-OHdG). 8-OHdG is one of the most exten-
sively studied and abundant free radical-induced oxidative DNA lesions, which also correlates with mutagenesis 
in bacterial and mammalian cells16. Based on this evidence, 8-OHdG has been widely used as a biomarker to eval-
uate the load of oxidative stress and carcinogenesis17. We found that 8-OHdG markedly increased in the lungs of 
e-cig rats (Fig. 2e). This was supported by an inverse correlation between FRAP and 8-OHdG in lung tissue from 
exposed animals (Fig. 2f).
Insights into the redox imbalance also emerged from the study of the lipidome (Fig. 2g). The main lipid classes 
(free fatty acids, free cholesterol, esterified cholesterol and triglycerides) were determined by GC/MS. After e-cig 
aerosol exposure, the overall lipid composition of rat plasma was markedly affected with significant increases in 
the content of esterified cholesterol (EC), total cholesterol (TC) and triglycerides (TG) (P < 0.05) (Fig. 2g). These 
results agree with those reported by recent literature studies18 showing increased concentrations of TG, VLDL and 
TG/HDL ratios after four weeks’ intraperitoneal injection of nicotine and e-cig refill liquid containing nicotine 
in rats. Since the liver is the main organ responsible for cholesterol and lipoprotein synthesis, exposure to e-cig 
vapours might have affected rat liver function. On the other hand, the nicotine could have triggered the release 
of catecholamines and cortisol, in turn leading to activation of adenyl cyclase in adipose tissue and lipolysis of 
stored TG, with a subsequent increase in plasma VLDL and TG19. Tobacco smoking is known to lead to signifi-
cantly higher serum concentrations of cholesterol and TG20–22. We did not explore the mechanism underlying this 
Figure 1. Metabolic/antioxidant enzymes and free radical yield in e-cig-exposed rat lung. (a) Cytochrome 
P450 (CYPs) is a superfamily of major isoenzymes involved in drug metabolism. CYP activities lead to the 
bioactivation of ubiquitous pre-mutagens and pre-carcinogens as well as ROS generation linked to their 
catalytic cycle. Data were obtained through enzymatic assays performed on microsomal lung fractions using 
several specific probes: MROD (CYP1A2-like) increased up to 262%, PROD (2B1/2) 384%, APD (3A, 1A, 
2A, 2D) 19% P < 0.05, 16-α TOH (2B1/2C11) 48% (P < 0.01), 17-TOH (3A1) 41% (P < 0.01). (b) EPR spectra 
of nitroxide radicals observed in rat lung tissues in control samples (green spectra), and in e-cig vapour-
treated samples (red spectra). (c) EPR intensity of the first spectral line of the observed nitroxide radicals 
(arbitrary units). (d) Antioxidant enzymes: CAT, NQO1 and SOD were reduced more than 32% (P < 0.01). (e) 
Transferases shown here are involved in the detoxifying step of xenobiotic metabolism making drugs or toxins 
more water-soluble. They also contribute to preserving DNA from adduct formation converting carcinogens 
into inactive or less toxic compounds: UDP-GT unchanged, GST 28% loss (P < 0.01). Each bar represents the 
means ± S.D. of ten measurements performed on ten rats, *P < 0.05, **P < 0.01, two-tailed t-test.
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phenomenon, but nonetheless consider the finding noteworthy. In addition, we detected significant variations 
in the fatty acid composition of plasma: in particular, the sum of C18:1-trans isomers significantly (P < 0.001) 
increased probably due to the interaction of reactive VOCs generated by e-cig and plasma lipids. A significant 
increase in saturated fatty acids (SFA) was also found, whereas the content of polyunsaturated fatty acids (PUFA) 
and PUFA n-6 series noticeably decreased (Fig. 2g). Recently, Shen et al.23 demonstrated that alterations in cel-
lular glycerophospholipid biosynthesis are an important consequence of e-cig vapour exposure due to enriched 
gene expression, and this could explain the fatty acid differences found here. However, in-depth histopathological 
investigation of diverse organs (such as liver) could yield more information on the lipidome changes found after 
e-cig aerosol exposure, and thereby shed more light on the underlying mechanisms involved.
To investigate the putative genotoxic potential of e-cig vapour, we considered various genetic endpoints at 
chromosomal and gene level in rat peripheral blood and urine, which served as body collectors of mutagenic 
metabolites. We observed that e-cigs produce extensive DNA damage in leukocytes measured as tail comet length 
of the fragmented DNA determined by single- and double-strand breaks (Fig. 3a,b). These data are in line with 
previous in vitro outcomes on HaCaT, UMSCC10B, and HN30 cell lines exposed to nicotine-containing and 
nicotine-free vapour extracts from two popular e-cig brands24. We also found that e-cig vapour determines an 
increase in the percentage of immature micronucleated reticulocytes (MN-RET) over normal reticulocyte RT 
(Fig. 3c,d). These results indicate that the mixture of chemical compounds generated by e-cigs leads to chromo-
some fragmentation and possibly damage to the mitotic spindle or centromeres. We observed a concomitant 
severe hematopoietic depression on exposed rats (Fig. 3e). Next, the urine of e-cig-exposed animals induced 
a dose-dependent increase in the number of S. typhimurium revertants in different strains. The highest sensi-
tivity was shown by the TA100 strain (Fig. 3f), revealing base substitutions, and YG1024 (Fig. 3g), disclosing 
frame-shift mutations with an increased sensitivity to nitroarenes and aromatic amines. Mutant induction was 
affected by the S9 external metabolic activation system, suggesting both mutagenic and promutagenic metabolites 
in the urine.
Despite its shortcomings, the work presented here strongly raises the possibility that e-cig consumption under 
certain conditions leads to toxicological outcomes directly and indirectly damaging DNA in the rat. As shown 
Figure 2. Systemic antioxidant capacity, oxidative DNA damage and lipidomics. (a) FRAP lung, loss >33% 
(P < 0.05). (b) FRAP plasma (P = 0.059). (c) FRAP plasma from e-cig group inversely correlated vs CO 
(r = 0.930, P < 0.001). (d) FRAP plasma from control group positively correlated vs CO (r = 0.880, P < 0.01). (e) 
8-OHdG lung levels markedly increased ~288% (P < 0.01). (f) FRAP lung from e-cig group inversely correlated 
vs 8-OHdG (r = 0.845, P < 0.05). Data (n = 5 measurements per group) are expressed as means ± standard 
error of the mean (SEM), analysed by one-way analysis of variance (ANOVA) (g) left side, content of esterified 
cholesterol, total cholesterol and triglycerides (mg/dL) determined by GC/MS and GC/FID for qualitative and 
quantitative analysis, respectively, on Control and E-cig groups. Right side, sum of C18:1 trans isomers, saturated 
fatty acids (SFA), polyunsaturated fatty acids (PUFA) and PUFA n-6 series (PUFA n-6) in percentage (%) of 
total fatty acids determined by GC/FID on Control and E-cig groups. Each bar represents the means ± S.D. of 
ten measurements performed on ten *P < 0.05, **P < 0.01, ***P < 0.001, two-tailed t-test.
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in Table 1, our GC/MS analysis of the vapour was consistent with the literature3 confirming the presence, among 
others, of acrolein, toxic and mutagenic compounds25. However, our study currently precludes any cause-effect 
speculation, ascribing responsibility for the effects detected to the vapour as a whole rather than the single com-
ponents. Our results should be construed as stemming from a preliminary study which was not conceived to 
replicate human vaping conditions, but to demonstrate if exposure to the chemical cocktail derived from e-cig 
liquid vaporization can result in toxicological injury.
As these detrimental phenomena are typically induced by conventional cigarettes26–28, the erroneous belief 
that e-cigs are safe should be retracted and suitable measures implemented to protect public health. Our study 
should be seen as the starting point for further investigations designed to confirm the harmful health impact of 
e-cigs, and a thorough analysis of their risk-benefit ratio, particularly after long-term exposure and under differ-
ent usage conditions.
Materials and Methods
E-cigarette and liquid refills. The electronic device (e-cigarette) was composed of a 2.5 mL liquid tank 
in Pyrex glass and a rechargeable lithium battery (3.7 Volt EH IMR 18650; 2000 mAh), coupled with a dual coil 
Figure 3. Genotoxicity of e-cig vapour. (a) Distribution of individual median TI% for the alkaline Comet 
assay. (b) Box-plot of TI%: primary DNA damage increase (P < 0.001). (c) Representative image of micronuclei 
(yellow MN-RET, orange RET, green erythrocytes (E). (d,e) MN-RET vs RET and RET vs E plus RET; MN-RET 
vs RET increased (P < 0.05); hematopoietic depression up to 50% loss, as RT fraction of total red blood cells, 
(P < 0.001). Error bars ± S.D. *P < 0.05; ***P < 0.001 two-tailed t-test. (f,g) Urinary mutagenesis: TA100 and 
YG1024 S. typhimurium revertants/plate increased in a dose-dependent manner ± S9 mix. *P < 0.05; **P < 0.01; 
***P < 0.001 Bonferroni’s test).
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atomizer (2 Ohm stainless steel resistance). The liquid used was purchased from BandZ S.r.l., (Pisa, Italy). The 
commercial brand is “Essential cloud, red fruit flavour”, 20 mL package, composition per 100 g of product: pro-
pylene glycol Ph.Eur., vegetable glycerine Ph.Eur., deionized water, flavours (“red fruits”), nicotine (18 mg/mL). 
Both e-cigarette and liquid refills were commercially available. The voltage was set at 5.5 V and the wattage was 
about 15 W.
Preliminary conditions and chamber assessment. Several chemical analyses were conducted to deter-
mine the best conditions for experimental animal exposure. In particular, O2, N2 and CO2 were measured in 
the exposure chamber using an airtight syringe to establish a suitable O2/CO2, O2/N2 ratio and nicotine level to 
avoid interference with animal health during the experiment. Air was sampled with a Hamilton airtight syringe 
(30 mL), immediately transferred into a 5-mL capped vial and injected into GC/MS (QP-2010 Plus, Shimadzu, 
Japan) equipped with A RTX-WAX column (30 m, 0.25 mm i.d., 0.25 μm film thickness, Restek, USA), interfaced 
with a computerized system for data acquisition (Software GC–MS Solution V. 2.5, Shimadzu, Japan). The essen-
tial condition for the experiment starting point was a modest decrease in oxygen level (less than 5%) and a slightly 
higher CO2 level after the entire exposure time.
Determination of total volatile compounds (VOCs). Volatile compounds (VOCs) were extracted by 
headspace-solid phase microextraction (HS-SPME)29 and determined by GC–MS (QP-2010 Plus, Shimadzu, 
Japan), interfaced with a computerized data acquisition system (Software GC/MS Solution V. 2.5, Shimadzu, 
Japan), as reported by Cardenia et al.30 with a few minor modifications. An RTX-WAX column (30 m, 0.25 mm 
i.d., 0.25 μm film thickness, Restek, USA) and an SPME device with a fused-silica fiber (10 mm length) coated 
with a triphasic stationary phase (DVB/CAR/PDMS of 50/30 mm thickness), were used. The fiber was exposed to 
the chamber headspace after 17 s of puff (6 s on, 5 s off, 6 s on) for 1 min. Thereafter, the fiber was withdrawn into 
the needle and transferred to the injection port of the GC/MS system. The chamber headspace was sampled in 
three different positions (in triplicate) in the first and last chamber of the cycle exposure treatment. Samples were 
analysed under the same analytical conditions previously reported14. The acquisition and integration modes were 
Full Scan (TIC). Compounds were identified by comparing their mass spectra with those reported in the NIST08 
(National Institute of Standards and Technology, Gaithersburg) library.
Animal exposure. All experiments were carried out according to EU Directive 2010/63/EU. The protocol 
was approved by the University of Bologna Committee on the Ethics of Animal Experiments and by the Italian 
Ministry of Health (Permit number 26832015).
Male Sprague Dawley rats were purchased from ENVIGO RMS S.r.l. (San Pietro al Natisone, Udine, Italy) at 8 
weeks of age. They were housed under a 12 h-light/12 h-dark cycle, 22 °C, 60% humidity, and fed ad libitum. After 
5 days’ adaptation, the rats were randomly split into two groups: non-exposed as the control group and exposed 
(10 animals per group). The treatment group was exposed using a whole-body mode. The inhalation chamber 
consisted of a propylene box (38 × 26.5 × 19 cm) with a capacity of 19 L. The pump (0.18 kW; 1.4/1.6 A; 230 V; 
50/60 Hz) was installed on one side of the box, while e-cigarette aerosol was puffed on the other. This mechanism 
generates airflow into the chamber. The chamber containing two animals at a time was not hermetically sealed 
and the two holes (e-cig and pump connection points) were left open. Animals were exposed in order to consume 
1 mL/day of e-liquid containing 18 mg/mL of nicotine. One cycle of treatment consisted in 17 s puff (6 s on, 5 s 
off, 6 s on) followed by 20 min stop. During the experiment the e-cigarette voltage was set at 5.5. At the end of 
the cycle the animals were transferred to a clean chamber to begin the next cycle. Animals were submitted to 11 
cycles/day for 5 consecutive days/week, and for 4 consecutive weeks.
Five additional rats were treated with mitomycin C (1 mg/kg, ip, single dose)31 to have positive controls for 
the micronucleus test. The animals were sacrificed no earlier than 24 h, but no later than 48 h after the treatment 
with mutagens, in order to collect tissues at the most appropriate timing to check the endpoints (micronuclei).
Tissue collection. Rats were fasted 16 h prior to sacrifice. Animals were anesthetized by administering 
Zoletil 100 (100 mg/kg b.w.) and then sacrificed by decapitation according to the Ministerial procedures approved 
for the species. Lungs were collected and put in liquid nitrogen. Blood (caudal vein access) and 12 h urine (using 
metabolic cages) were also collected. Whole blood was collected for Comet assay and micronucleus test, while 
another fraction was decanted into anticoagulant tubes and centrifuged at 1,000 × g for 10 min to obtain plasma 
for the other parameter determinations (carbonyl residues (CO); ferric reducing ability of plasma (FRAP)).
Subcellular fractions. Microsomes and cytosolic fraction were prepared as previously reported32.
Xenobiotic phase-I/phase-II metabolism and antioxidant enzymes. All the assays have been 
described in detail elsewhere33, 34.
Protein concentration. It was determined according to the method described by Lowry et al.35 using bovine 
serum albumin as standard and diluting microsomes 200 times and cytosol 1,000 times to provide a suitable 
protein concentration.
Electronic paramagnetic resonance (EPR) measurements. Immediately before measurement, the 
frozen lung tissues were dissolved in a physiological solution containing the hydroxylamine “spin trap” (bis(
1-hydroxy-2,2,6,6-tetramethyl-4-piperidinyl) decandioate dihydrochloride CAS no. 314726-62-0), and warmed 
for 5 min at 37 °C. The samples obtained were transferred and sealed in a calibrated capillary glass tube, which 
was placed inside the thermostated cavity (at room temperature) of a Bruker ESP 300 EPR spectrometer 
(Bruker Biospin S.r.l., Rheinstetten, Germany) equipped with a nuclear magnetic resonance gaussmeter for field 
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calibration, a Bruker ER 033M FF-lock (Bruker Biospin S.r.l.) and a Hewlett-Packard 5350B microwave frequency 
counter (Hewlett Packard, Houston, TX, USA). The actual amount of solution analysed was chosen so as to cover 
the entire sensitive area of the instrument cavity. The spectra of the nitroxide radical, generated by the reaction of 
the probe with the radicals produced in the tissues, were then recorded using the following instrumental settings: 
modulation amplitude = 1.0 G; conversion time = 163.84 ms; time constant = 163.84 ms; modulation frequency 
100 kHz; microwave power = 6.4 mW. The intensity of the first spectral line of the nitroxide (aN = 16.90 G and 
g = 2.0056) was used to obtain the relative amount of nitroxide in each examined samples. The calibration of the 
spectrometer response was done by using a known solution of TEMPO-coline in water and an ER 4119HS Bruker 
Marker Accessory as internal standard. The hydroxylamine probe was prepared as previously described36, 37.
FRAP assay. This determination was performed in plasma and lung tissues. FRAP reagent (900 mL) contain-
ing 10 mM 2,4,6-tripyridyl-S-triazine in 40 mM HCl, 300 mM acetate buffer (pH 3.6) and 20 mM FeCl3 was added 
to 30 µL of plasma or supernatant tissue. The change in absorbance (at 593 nm) between the final reading and the 
blank was calculated for each sample and related to the absorbance of ferric standard solutions38.
8-hydro-2′-deoxyguanosine (8-OHdG) assay. This test was performed as previously reported39. Briefly, 
the lung was homogenized in 50 mM phosphate buffer solution (PBS) containing 0.1 M dithiothreitol and then 
centrifuged at 4 °C for 20 min at 2,000 × g. The pellets were resuspended and the DNA isolated. The purified DNA 
(about 30 µg) was hydrolysed with P1 nuclease (10 IU) and alkaline phosphatase (7 IU). The hydrolysed mixture 
was filtered using Micropure-EZ enzyme remover (Amicon, MA, USA) and 50 µL was injected into an HPLC 
apparatus. The nucleosides were separated by a C18 reverse-phase column (Supelco, 5 μm particle size, 0.46 cm 
I.D., 25 cm length). The 8-OHdG and 2 dG in the DNA were detected using an ESA Coulochem II electrochemical 
detector.
Carbonyl residues. This determination was performed in the plasma and/or supernatant tissue40.
Lipidomics analysis. Free fatty acids, esterified cholesterol, free cholesterol, triglycerides and total fatty acids 
were determined as reported in our previous work41 using GC/FID and GC/MS.
Alkaline Comet assay. Directly withdrawn whole blood (10 µL) was added to 80 µL of 0.65% low melting 
agarose (LMA) in PBS. 5 µL of this solution were transferred onto degreased microscope slides previously dipped 
in 1% normal melting agarose using a 12-gel Comet assay unit (Severn Biotech Ltd, Worcestershire, UK). The 
agarose was allowed to set for 10 min. After agarose solidification, the slides were placed in lysing solution (2.5 M 
NaCl, 100 mM Na2EDTA, 10 mM Tris-HCl, 1% Triton X-100 and 10% DMSO, pH 10) in a Coplin jar at 4 °C 
overnight in the dark. Alkaline DNA unwinding was carried out in a gel electrophoresis chamber containing a 
freshly prepared buffer (1 mM Na2EDTA, 300 mM NaOH, pH 13) for 20 min and electrophoresis was performed 
in the same buffer for 20 min at 0.78 Vcm-1 and 300 mA. DNA unwinding and electrophoresis were performed 
in an ice-water bath. After electrophoresis the slides were washed in a neutralization buffer (0.4 M Tris-HCl, pH 
7.5). All the steps described above were performed under a yellow light to minimize additional UV-induced DNA 
damage. After staining with 100 µL ethidium bromide (10 µg/mL), observations were made under a fluorescence 
microscope (Leica DMLS) equipped with an excitation filter BP 515–560 nm and a barrier filter LP 580 nm, using 
an image analysis system (Comet Assay IV– Perceptive Instruments Ltd, UK). DNA fragmentation tail (TI, tail 
intensity) provided representative data on the genotoxic effects. For each specimen 100 cells were analysed.
Micronucleus test. After recoding to allow blinded analysis, smears of peripheral blood were 
methanol-fixed, stained with acridine orange (CAS Number 65-61-2, Sigma Aldrich) and analysed under fluo-
rescence microscopy. For each animal 4,000 reticulocytes were scored to determine micronuclei frequency and 
4,000 erythrocytes were scored to determine the ratio between reticulocytes and the sum of reticulocytes and 
erythrocytes. As positive controls, 1 mg/kg b.w. of mitomycin was administered i.p. as described above31.
Ames test. Urine extracts were dissolved in DMSO (25 mLeq urine/mL) and tested with the Ames test in 
triplicate at increasing concentrations (0.025–2.500 mLeq urine /plate) using Salmonella typhimurium TA100 
and YG1024 strains, with and without microsomal activation (S9 mix) to detect indirect and direct mutagenic 
compounds, respectively. Positive controls were 2-aminofluorene (2-AF; 5 µg/plate) for both strains with S9 and 
hycanthone (HY; 50 µg/plate) for both strains without S9. DMSO was tested as negative control. The Ames test 
data are reported as means of three independent replicates of revertants/plate42.
Statistical analysis. Where not differentially specified, data are expressed as means ± standard deviation 
(S.D.) of ten measurements on ten rats for each studied group. Data from the study on volatile compounds 
(VOCs) and those obtained from the preliminary tests to set the experimental conditions of the exposure cham-
ber were analysed using Tukey’s test. Results from xenobiotic metabolizing enzymes and antioxidant enzymes 
were analysed using the two-tailed unpaired t-test with the multiple-comparison post-hoc analysis (Holm-Sedak). 
Data from FRAP assay 8-OHdG, and CO (n = 5 measurements per group), were analysed using the two-tailed 
unpaired t-test. The micronucleus test was statistically analysed using the two-tailed unpaired t-test. Tukey’s test 
was used to analyse data from the lipidomics study. For the Comet assay and Ames test the distributions of the 
variables were preliminarily assessed by means of the one-sample Kolmogorov-Smirnov test, and parametric 
statistical tests were applied to normally distributed variables. The mean values from the repeated experiments 
were used in a one-way analysis of variance (ANOVA). If significant F-values (P < 0.05) were obtained, post hoc 
Student’s t test (Bonferroni’s version) was conducted for pairwise comparison. P values < 0.05 were considered 
statistically significant.
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